Actavis Ireland


Press Releases

29 FEB 2012 / Product News

 

Actavis launches Desloratadine

Desloratadine ActavisDesloratadine Actavis

 

 

 

 

 

 

 

Actavis Ireland is delighted to announce the addition of Desloratadine Actavis 5mg x 30 Film coated tablets to the company’s growing portfolio.

Desloratadine Actavis is the second in a range of anti–allergy products launched by Actavis this year. Together with numerous other product launches planned for this year, they will further add to Actavis’ sustained position as the fastest growing generic company in Ireland. *
Desloratadine Actavis is GMS reimbursable (35701) and subject to medical prescription.

For more information on Desloratadine please see the product section of this website

For further information on the Actavis portfolio please contact us in Cork today on 1890 33 32 31.

  • go back
  • print
  • send